GlassScriptPhysician profile
Gary A Tannenbaum
NPI 1811949670
$114,996.98
in general payments reported to CMS, 2019-2025
40 companies · $7,404 in 2025
The $7,404 reported for 2025 was more than what 88% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $945 · 2020: $8,214 · 2021: $17K · 2022: $29K · 2023: $34K · 2024: $19K · 2025: $7,404.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $57K · Food and Beverage: $2,843 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $57,473.34 |
| Food and Beverage | $2,842.92 |
| Education | $137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $108,837.24 | 2020-2025 | Auryon Laser System 100-120 Vac, Venacure 1470 Pro, Venacure 1470 Pro |
| Organogenesis INC. | $934.56 | 2021-2025 | Apligraf, Puraply Wound Matrix, Nushield |
| Endologix LLC | $659.27 | 2021 | |
| Smith+Nephew, INC. | $437.71 | 2019-2025 | Collagenase Santyl, Oasis, Grafix Pl |
| Janssen Pharmaceuticals, INC | $420.91 | 2019-2024 | Xarelto |
| Kci USA, INC. | $400.00 | 2019 | |
| Terumo Medical Corporation | $394.69 | 2020-2023 | Angio-Seal, Metacross Otw |
| Polynovo North America LLC | $233.81 | 2024-2025 | Novosorb Btm |
| Bard Peripheral Vascular, INC. | $233.55 | 2021-2022 | |
| Stryker Corporation | $232.16 | 2025 | Flowtriever, Clottriever Bold Catheter, Artix Mt |
| Philips North America LLC | $232.03 | 2019-2020 | |
| Lifenet Health | $182.93 | 2025 | Theragenesis Wound Matrix |
| Cook Medical LLC | $160.37 | 2019-2020 | |
| Medical Device Business Services, INC. | $137.01 | 2023 | Stratafix |
| Pfizer INC. | $135.44 | 2020-2024 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $132.29 | 2021-2025 | Endurant Iis, Heli-Fx Endoanchor System |
| W. L. Gore & Associates, INC. | $124.85 | 2021 | |
| Mozarc Medical US LLC | $119.05 | 2024 | Argyle |
| Medtronic Vascular, INC. | $113.24 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $97.81 | 2019-2023 | Eliquis |
| Solventum Corporation | $85.80 | 2024-2025 | Activ.A.C., Promogran Prisma, 3m Coban |
| Abbvie INC. | $78.14 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $75.79 | 2019 | |
| Resmed Corp | $58.71 | 2022 | |
| Tactile Systems Technology INC | $45.75 | 2020-2022 | |
| Integra Lifesciences Corporation | $45.01 | 2025 | Tcc-Ez |
| Cardinal Health 200 LLC | $38.54 | 2020-2021 | |
| Abbott Laboratories | $38.09 | 2019-2025 | Esprit |
| Hydrofera LLC | $37.90 | 2024-2025 | Hydrofera Blue |
| Innovation Technologies INC | $36.58 | 2024 | Irrisept |
| Urgo Medical North America, LLC | $34.69 | 2024-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2 |
| Penumbra, INC. | $33.02 | 2020-2024 | Penumbra System |
| Baxter Healthcare | $27.17 | 2024 | Renal - Pd |
| Shockwave Medical, INC | $24.29 | 2022 | |
| Cardiva Medical, INC. | $23.20 | 2021 | |
| Next Science LLC | $21.78 | 2025 | Xperience, Blastx |
| Allergan, INC. | $19.68 | 2019 | |
| Cardiovascular Systems INC. | $19.43 | 2019-2020 | |
| Covidien LP | $18.55 | 2019 | |
| Boston Scientific Corporation | $15.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Tannenbaum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.